Skip to main content
. 2012 Nov 21;75(6):1433–1444. doi: 10.1111/bcp.12042

Figure 1.

Figure 1

Light transmission platelet aggregometry in healthy subjects and patients with sickle cell disease (SCD) before and after prasugrel treatment. Maximal platelet aggregation, measured by light transmission aggregometry, in response to 5 μm (A) and 20 μm (B) ADP at baseline before prasugrel treatment and following 12 days of prasugrel treatment in healthy subjects (n = 13) and in patients with sickle cell disease (n = 13). Inline graphic, baseline; Inline graphic, day 12